UY31038A1 - Compuestos - Google Patents

Compuestos

Info

Publication number
UY31038A1
UY31038A1 UY31038A UY31038A UY31038A1 UY 31038 A1 UY31038 A1 UY 31038A1 UY 31038 A UY31038 A UY 31038A UY 31038 A UY31038 A UY 31038A UY 31038 A1 UY31038 A1 UY 31038A1
Authority
UY
Uruguay
Prior art keywords
compounds
compounds containing
containing nitrogen
antibacterial agents
tricyclic compounds
Prior art date
Application number
UY31038A
Other languages
English (en)
Inventor
Paerson Neil David
Hennessy Alan Joseph
Giordano Llaria
Davies David Thomas
Davies David Evan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31038(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0707705A external-priority patent/GB0707705D0/en
Priority claimed from GB0720569A external-priority patent/GB0720569D0/en
Priority claimed from GB0805311A external-priority patent/GB0805311D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of UY31038A1 publication Critical patent/UY31038A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

Compuestos tricíclicos que contienen nitrogeno y su uso como agentes antibacterianos.
UY31038A 2007-04-20 2008-04-18 Compuestos UY31038A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0707705A GB0707705D0 (en) 2007-04-20 2007-04-20 Compounds
GB0720569A GB0720569D0 (en) 2007-10-19 2007-10-19 Compounds
GB0805311A GB0805311D0 (en) 2008-03-20 2008-03-20 Compounds

Publications (1)

Publication Number Publication Date
UY31038A1 true UY31038A1 (es) 2008-11-28

Family

ID=39580226

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31038A UY31038A1 (es) 2007-04-20 2008-04-18 Compuestos

Country Status (32)

Country Link
US (1) US8389524B2 (es)
EP (1) EP2137196B1 (es)
JP (1) JP5389013B2 (es)
KR (1) KR101567096B1 (es)
CN (1) CN101687887B (es)
AR (1) AR066111A1 (es)
AT (1) ATE483717T1 (es)
AU (1) AU2008240764C1 (es)
BR (1) BRPI0810064B8 (es)
CA (1) CA2684659C (es)
CL (1) CL2008001122A1 (es)
CO (1) CO6251368A2 (es)
CR (2) CR11123A (es)
CY (1) CY1111248T1 (es)
DE (1) DE602008002912D1 (es)
DK (1) DK2137196T3 (es)
DO (1) DOP2009000240A (es)
EA (1) EA015821B1 (es)
HK (1) HK1138000A1 (es)
HR (1) HRP20100574T1 (es)
IL (1) IL201204A0 (es)
MA (1) MA31324B1 (es)
MX (1) MX2009011317A (es)
MY (1) MY149347A (es)
NZ (1) NZ579877A (es)
PE (1) PE20090274A1 (es)
PL (1) PL2137196T3 (es)
PT (1) PT2137196E (es)
SI (1) SI2137196T1 (es)
TW (1) TWI431006B (es)
UY (1) UY31038A1 (es)
WO (1) WO2008128942A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200801128A1 (ru) * 2005-10-21 2008-10-30 Глэксо Груп Лимитед Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
US8486948B2 (en) 2007-10-19 2013-07-16 Boehringer Ingelheim International Gmbh Piperazinodihydrothienopyrimidine derivatives
KR20100075930A (ko) * 2007-10-19 2010-07-05 베링거 인겔하임 인터내셔날 게엠베하 헤테로사이클-치환된 피페라지노-디하이드로티에노피리미딘
UA99309C2 (ru) * 2007-10-19 2012-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Замещенные пиперидинодигидротиенопиримидины
WO2009104147A2 (en) 2008-02-20 2009-08-27 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
JP2011520944A (ja) * 2008-05-23 2011-07-21 グラクソ グループ リミテッド 窒素含有三環式化合物および抗菌剤としてのその使用
CA2725726A1 (en) * 2008-05-23 2009-11-26 Glaxo Group Limited Tricyclic nitrogen containing compounds and their use as antibacterials
DK2344495T3 (en) 2008-10-07 2015-02-02 Actelion Pharmaceuticals Ltd TRICYCLIC OXAZOLIDINON ANTIBIOTIC COMPOUNDS
EP2352734A1 (en) * 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
EP2387567B1 (en) 2009-01-14 2014-06-11 The Salk Institute for Biological Studies Compounds that protect against amyloid diseases
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
ES2834973T3 (es) 2010-05-04 2021-06-21 Alkermes Pharma Ireland Ltd Procedimiento de síntesis de compuestos de lactama oxidada
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
JP6453216B2 (ja) * 2013-07-23 2019-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ縮合環化合物
CR20170069A (es) * 2014-08-22 2017-04-28 Glaxosmithkline Intelectual Property Dev Ltd Compuestos tricíclicos que contienen nitrógeno para el tratamiento de la infección por neisseria gonorrhoeae
WO2017223290A1 (en) * 2016-06-22 2017-12-28 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
EP3612513A4 (en) 2017-04-17 2020-09-30 Ohio State Innovation Foundation TYPE II TOPOISOMERASE INHIBITORS AND METHOD OF MANUFACTURING AND USING THEREOF
BR112021018815A2 (pt) 2019-04-03 2022-03-03 Glaxosmithkline Ip Dev Ltd Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário
BR112021024845A2 (pt) 2019-07-05 2022-01-18 Glaxosmithkline Ip Dev Ltd Combinação para o tratamento de infecções causadas por mycoplasma genitalium
BR112022018315A2 (pt) 2020-04-02 2022-10-25 Glaxosmithkline Ip Dev Ltd Regime para tratar a infecção por neisseria gonorrhoeae com gepotidacina
EP4143188A1 (en) 2020-04-29 2023-03-08 GlaxoSmithKline Intellectual Property Development Limited Crystalline forms of gepotidacin
CN111494241B (zh) * 2020-06-01 2023-03-24 湖北洁世达环保科技有限公司 一种纸巾柔润保湿液
JP2024506013A (ja) 2021-02-05 2024-02-08 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 経口固体用量製剤
WO2023139147A1 (en) 2022-01-21 2023-07-27 Glaxosmithkline Intellectual Property Development Limited Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus
EP4316463A1 (en) 2022-08-02 2024-02-07 GlaxoSmithKline Intellectual Property Development Limited Novel formulation
WO2024068524A1 (en) 2022-09-26 2024-04-04 Glaxosmithkline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial prostatitis

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403610B1 (en) 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6525049B2 (en) 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
CZ2003243A3 (cs) 2000-07-26 2003-09-17 Smithkline Beecham P. L. C. Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (en) 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2002350217A1 (en) 2001-12-04 2003-06-17 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
JP4445753B2 (ja) 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
AU2003301414B8 (en) 2002-10-10 2010-06-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Novel compounds with antibacterial activity
US7232832B2 (en) 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7348434B2 (en) 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7691850B2 (en) 2004-06-15 2010-04-06 Glaxo Group Limited Antibacterial agents
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006014580A1 (en) 2004-07-08 2006-02-09 Glaxo Group Limited Antibacterial agents
US20080194547A1 (en) 2004-07-09 2008-08-14 Glaxo Group Limited Antibacterial Agents
EP1773343A4 (en) 2004-07-13 2009-05-13 Glaxo Group Ltd ANTIBACTERIAL AGENTS
EP1778688A1 (en) 2004-07-22 2007-05-02 Glaxo Group Limited Antibacterial agents
ATE484509T1 (de) 2004-08-02 2010-10-15 Glaxo Group Ltd Antibakterielle mittel
WO2006020561A2 (en) 2004-08-09 2006-02-23 Glaxo Group Limited Antibacterial agents
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2006032466A2 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
CA2581057A1 (en) 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
JP2008528587A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
EP1846411A4 (en) 2005-01-25 2010-08-04 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
NZ562034A (en) 2005-03-31 2009-10-30 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as antibacterial agents
US20090131444A1 (en) 2005-05-24 2009-05-21 Astrazeneca Ab Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
DE602006008932D1 (de) 2005-05-25 2009-10-15 Actelion Pharmaceuticals Ltd Neue antibiotische derivate
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (ja) * 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
EA200801128A1 (ru) * 2005-10-21 2008-10-30 Глэксо Груп Лимитед Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств
EP1963324B1 (en) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
US7709483B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
EP2029612A1 (en) 2006-06-09 2009-03-04 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
EP2137196B1 (en) 2010-10-06
PE20090274A1 (es) 2009-04-03
AU2008240764C1 (en) 2011-10-20
CR20150586A (es) 2016-04-04
CA2684659C (en) 2015-11-24
AR066111A1 (es) 2009-07-22
PL2137196T3 (pl) 2011-03-31
MY149347A (en) 2013-08-30
CN101687887A (zh) 2010-03-31
WO2008128942A1 (en) 2008-10-30
EP2137196A1 (en) 2009-12-30
CA2684659A1 (en) 2008-10-30
MX2009011317A (es) 2009-11-05
ATE483717T1 (de) 2010-10-15
TWI431006B (zh) 2014-03-21
NZ579877A (en) 2011-09-30
JP2010524884A (ja) 2010-07-22
BRPI0810064B8 (pt) 2021-05-25
CR11123A (es) 2010-03-08
IL201204A0 (en) 2010-05-17
AU2008240764A1 (en) 2008-10-30
CL2008001122A1 (es) 2008-10-24
DE602008002912D1 (de) 2010-11-18
TW200848420A (en) 2008-12-16
CY1111248T1 (el) 2015-06-11
EA200970987A1 (ru) 2010-04-30
DOP2009000240A (es) 2009-12-31
PT2137196E (pt) 2010-12-16
KR101567096B1 (ko) 2015-11-06
DK2137196T3 (da) 2011-01-10
JP5389013B2 (ja) 2014-01-15
BRPI0810064A2 (pt) 2019-08-27
CN101687887B (zh) 2012-08-29
HK1138000A1 (en) 2010-08-13
US20100137282A1 (en) 2010-06-03
SI2137196T1 (sl) 2011-01-31
MA31324B1 (fr) 2010-04-01
US8389524B2 (en) 2013-03-05
CO6251368A2 (es) 2011-02-21
AU2008240764B2 (en) 2011-04-07
KR20100017133A (ko) 2010-02-16
BRPI0810064B1 (pt) 2021-03-30
EA015821B1 (ru) 2011-12-30
HRP20100574T1 (hr) 2010-12-31

Similar Documents

Publication Publication Date Title
UY31038A1 (es) Compuestos
CR9930A (es) Compuestos
CL2007000311A1 (es) Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer.
CL2012000752A1 (es) Compuestos derivados de fenilpiri(mi)dinilpirazoles para el control de microorganismos no deseados en la proteccion de plantas y compuestos intermediarios.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
ECSP10010722A (es) Compuestos orgánicos
CO7101240A2 (es) Compuestos ß-lactámicos sustituidos con amidina, su preparación y uso como agentes bacterianos
CL2007001995A1 (es) Compuestos derivados de pirrolotriazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el cancer.
CR9786A (es) Compuestos de bencimidazol-tiofeno
ATE486079T1 (de) Azatricyclische verbindungen und deren verwendung
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
CR20120158A (es) Compuestos de diòxido de iminotiadiazina como inhibidores de bace, composiciones y su uso.
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
UY32659A (es) Pirazinilpirazoles
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
GT200500385A (es) Aminoalcoholes triciclicos, procedimientos para su preparacion y su uso como inhibidores de inflamacion
BRPI0912995A2 (pt) compostos tricíclicos contendo nitrogênio e sua utilização como agentes antibacterianos
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
ES2422173T3 (es) Composiciones que contienen aecuorina y procedimientos de uso de las mismas
CR20150080A (es) Derivados y analogos de n-etilquinolonas y n-etilazaquinolonas
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
CL2012000355A1 (es) Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc.

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20200417